Free cash flow
XPO Free cash flow decreased by 40.0% to $72.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 226.3%, from -$57.00M to $72.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Detailed definition
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Peer comparison
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flowHistorical Data
| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $401.00M | $41.00M | $77.00M | $38.00M | $159.00M | $29.00M | -$148.00M | -$788.00M | -$161.00M | $23.00M | -$57.00M | $51.00M | $215.00M | $120.00M | $72.00M |
| QoQ Change | — | -89.8% | +87.8% | -50.6% | +318.4% | -81.8% | -610.3% | -432.4% | +79.6% | +114.3% | -347.8% | +189.5% | +321.6% | -44.2% | -40.0% |
| YoY Change | — | — | — | -90.5% | — | -29.3% | -292.2% | <-999% | -8.8% | +102.9% | +64.6% | — | — | +421.7% | +226.3% |
Free cash flow at Other Companies
Frequently Asked Questions
- What is XPO's free cash flow?
- XPO (XPO) reported free cash flow of $72.00M in Q1 2026.
- How has XPO's free cash flow changed year-over-year?
- XPO's free cash flow increased by 226.3% year-over-year, from -$57.00M to $72.00M.
- What does free cash flow mean?
- The cash remaining after a company pays for its operating expenses and capital investments.